# A Study of SHR-1918 In Participants With Hypertriglyceridemia

> **NCT07349615** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beijing Suncadia Pharmaceuticals Co., Ltd** · enrollment: 360 (estimated)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** SHR-1918/ SHR-1918 placebo
- **DRUG:** SHR-1918/ SHR-1918 placebo

## Key facts

- **NCT ID:** NCT07349615
- **Lead sponsor:** Beijing Suncadia Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349615, "A Study of SHR-1918 In Participants With Hypertriglyceridemia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07349615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*